Haici Biological Pharmaceutical Co., Ltd., a wholly-owned subsidiary invested
by Yangtze River Pharmaceutical Group in 2004, is located in Binjiang Industrial
Park, Medical New & Hi-tech Industrial Development Zone. It is the research and
development, pilot test and production base of chemical API of the Group. It
is mainly engaged in the technical research, production and sales of high
value-added APIs and pharmaceutical intermediates.The company has
accumulated 24 product standards that have reached the international leading
level, 30 products have been recognized as provincial high-tech products, and
25 national invention patents have been authorized, Many products have been
successfully registered and sold in 9 countries. For example, the company
is currently the only domestic company that has mastered the preparation
process of tamoxifen citrate crystal form A, making the group the first to pass
the consistency evaluation of this product in China and market the product to
the international market.
Oceania; Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South East Asia (e.g. Thailand, Philippines, Singapore)
Primary business activity
Academic/Research; Contract Service; Distributor/Import Export; Licensee; Manufacturer/Innovator
Categories affiliated with Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Co., Ltd.
Are you a supplier?
Here's what CPhI Online can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation